MARKET

TCMD

TCMD

Tactile Sys Tech
NASDAQ

Real-time Quotes | Nasdaq Last Sale

42.57
+4.01
+10.40%
After Hours: 42.50 -0.07 -0.16% 16:00 04/07 EDT
OPEN
39.84
PREV CLOSE
38.56
HIGH
43.12
LOW
38.58
VOLUME
366.20K
TURNOVER
--
52 WEEK HIGH
71.65
52 WEEK LOW
29.47
MARKET CAP
818.06M
P/E (TTM)
75.87
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 7 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average TCMD stock price target is 66.40 with a high estimate of 72.00 and a low estimate of 62.00.

EPS

TCMD News

More
  • BTIG Maintains Buy on Tactile Systems Tech, Lowers Price Target to $63
  • Benzinga · 13h ago
  • Tactile Systems Pre-Releases 1Q; Pulls FY20 Guidance on Covid-19
  • SmarterAnalyst · 17h ago
  • Tactile systems Technology pulls FY20 outlook
  • Seeking Alpha - Article · 1d ago
  • Tactile Systems Technology Reports Preliminary Q1 Revenue Results Of $43M-$44M; The Company Also Withdraws Its FY20 Guidance Due To Coronavirus
  • Benzinga · 1d ago

Industry

Medical Equipment, Supplies & Distribution
-1.80%
Healthcare Equipment & Supplies
-1.46%

Hot Stocks

Symbol
Price
%Change

About TCMD

Tactile Systems Technology, Inc. is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency. Its products deliver long-term treatment of chronic diseases. The Company provides its products for use in the home and sells them through vascular, wound and lymphedema clinics throughout the United States. The Company offers a platform to deliver at-home healthcare solutions throughout the United States. Its initial area of therapeutic focus is vascular disease, with a focus on advancing the care in treating lymphedema and chronic venous insufficiency.
More

Webull offers kinds of Tactile Systems Technology Inc stock information, including NASDAQ:TCMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TCMD stock news, and many more online research tools to help you make informed decisions.